Masimo Stock Forecast, Price & News

Masimo (NASDAQ:MASI) Frequently Asked Questions

Is Masimo a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Masimo stock.
View analyst ratings for Masimo or view top-rated stocks.

How has Masimo's stock been impacted by Coronavirus (COVID-19)?

Masimo's stock was trading at $182.64 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MASI shares have increased by 51.7% and is now trading at $277.10.
View which stocks have been most impacted by COVID-19.

When is Masimo's next earnings date?

Masimo is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Masimo.

How were Masimo's earnings last quarter?

Masimo Co. (NASDAQ:MASI) announced its quarterly earnings results on Monday, October, 25th. The medical equipment provider reported $0.94 EPS for the quarter, topping the Zacks' consensus estimate of $0.91 by $0.03. The medical equipment provider had revenue of $307.40 million for the quarter, compared to the consensus estimate of $295.79 million. Masimo had a net margin of 19.23% and a trailing twelve-month return on equity of 15.56%. Masimo's revenue for the quarter was up 10.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.80 EPS.
View Masimo's earnings history.

What guidance has Masimo issued on next quarter's earnings?

Masimo issued an update on its FY 2021 earnings guidance on Tuesday, November, 2nd. The company provided EPS guidance of $3.880-$3.880 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.790. The company issued revenue guidance of $1.23 billion-$1.23 billion, compared to the consensus revenue estimate of $1.22 billion.

What price target have analysts set for MASI?

3 analysts have issued 1-year price objectives for Masimo's shares. Their forecasts range from $285.00 to $330.00. On average, they anticipate Masimo's stock price to reach $308.33 in the next year. This suggests a possible upside of 11.3% from the stock's current price.
View analysts' price targets for Masimo or view top-rated stocks among Wall Street analysts.

Who are Masimo's key executives?

Masimo's management team includes the following people:

• Joe E. Kiani, Chairman & Chief Executive Officer
• Bilal Muhsin, Chief Operating Officer
• Micah Young, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
• Yongsam Lee, Chief Information Officer & Executive VP
• Anand Sampath, Executive VP-Operations & Clinical Research

What is Joe E. Kiani's approval rating as Masimo's CEO?

136 employees have rated Masimo CEO Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among Masimo's employees.

Who are some of Masimo's key competitors?

Some companies that are related to Masimo include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), DexCom (DXCM), IDEXX Laboratories (IDXX), Baxter International (BAX), ResMed (RMD), STERIS (STE), Hologic (HOLX), Insulet (PODD) and Teleflex (TFX).
View all of MASI's competitors.

What other stocks do shareholders of Masimo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO).

What is Masimo's stock symbol?

Masimo trades on the NASDAQ under the ticker symbol "MASI."

Who are Masimo's major shareholders?

Masimo's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (16.11%), Ownership Capital B.V. (3.64%), Invesco Ltd. (2.10%), Massachusetts Financial Services Co. MA (1.53%), RTW Investments LP (1.51%) and Credit Suisse AG (1.42%). Company insiders that own Masimo stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Sanford Fitch, Steven Barker, Thomas Samuel Mcclenahan and Yongsam Lee.
View institutional ownership trends for Masimo.

Which institutional investors are selling Masimo stock?

MASI stock was sold by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Eagle Asset Management Inc., Credit Suisse AG, Citigroup Inc., Schroder Investment Management Group, Ensemble Capital Management LLC, UBS Group AG, and Goldman Sachs Group Inc.. Company insiders that have sold Masimo company stock in the last year include Anand Sampath, Craig B Reynolds, Joe E Kiani, and Micah W Young.
View insider buying and selling activity for Masimo or view top insider-selling stocks.

Which institutional investors are buying Masimo stock?

MASI stock was purchased by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Sumitomo Mitsui Trust Holdings Inc., Martin Currie Ltd., Mitsubishi UFJ Trust & Banking Corp, Ownership Capital B.V., Morgan Stanley, Eversept Partners LP, and BNP Paribas Asset Management Holding S.A..
View insider buying and selling activity for Masimo or or view top insider-buying stocks.

How do I buy shares of Masimo?

Shares of MASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Masimo's stock price today?

One share of MASI stock can currently be purchased for approximately $277.10.

How much money does Masimo make?

Masimo has a market capitalization of $15.30 billion and generates $1.14 billion in revenue each year. The medical equipment provider earns $240.30 million in net income (profit) each year or $4.01 on an earnings per share basis.

How many employees does Masimo have?

Masimo employs 5,300 workers across the globe.

When was Masimo founded?

Masimo was founded in 1989.

What is Masimo's official website?

The official website for Masimo is www.masimo.com.

Where are Masimo's headquarters?

Masimo is headquartered at 52 DISCOVERY, IRVINE CA, 92618.

How can I contact Masimo?

Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The medical equipment provider can be reached via phone at (949) 297-7000, via email at [email protected], or via fax at 949-297-7001.